kencarrot的个人主页 - 老虎社区

kencarrot

kencarrot

暂无个人介绍

IP属地：未知

49关注

27粉丝

0主题

0勋章

2021-07-02

Nice

抱歉，原内容已删除

2021-11-26

Lol

抱歉，原内容已删除

2021-07-22

Ggwp

Bilibili fell over 5% in morning trading<blockquote>哔哩哔哩早盘跌超5%</blockquote>

2021-06-30

More yays

抱歉，原内容已删除

2021-11-27

Lol

抱歉，原内容已删除

2021-11-24

Lol

抱歉，原内容已删除

2021-08-22

Lol

American consumers’ gray mood could put the S&P 500 in the green over the next 6 months<blockquote>美国消费者的灰色情绪可能会让标普500在未来6个月内变得绿色</blockquote>

2021-08-08

Like

抱歉，原内容已删除

2021-06-23

Good news

抱歉，原内容已删除

2021-11-13

Ok

Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3581764784067746","uuid":"3581764784067746","gmtCreate":1618673007619,"gmtModify":1619229631005,"name":"kencarrot","pinyin":"kencarrot","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":27,"headSize":49,"tweetSize":370,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.16","exceedPercentage":"93.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.07","exceedPercentage":"60.94%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.11","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":698412046,"gmtCreate":1640491014585,"gmtModify":1640491255732,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"lol","listText":"lol","text":"lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698412046","repostId":"691274673","repostType":1,"repost":{"id":691274673,"gmtCreate":1640216888125,"gmtModify":1640217059834,"author":{"id":"3582057972137750","authorId":"3582057972137750","name":"lcy12345","avatar":"https://static.tigerbbs.com/60aee26f012bbdfb2a9fa32495e56508","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582057972137750","authorIdStr":"3582057972137750"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>oh no, I missed the below 900 train!! :-((( congrats to everyone who got it at such a steal!!&nbsp;","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>oh no, I missed the below 900 train!! :-((( congrats to everyone who got it at such a steal!!&nbsp;","text":"$Tesla Motors(TSLA)$oh no, I missed the below 900 train!! :-((( congrats to everyone who got it at such a steal!!","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691274673","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2304,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691677220,"gmtCreate":1640189448455,"gmtModify":1640189448751,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691677220","repostId":"1158577227","repostType":4,"repost":{"id":"1158577227","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640178165,"share":"https://www.laohu8.com/m/news/1158577227?lang=zh_CN&edition=full","pubTime":"2021-12-22 21:02","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158577227","media":"Tiger Newspress","summary":"U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally","content":"<p>U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.</p><p><blockquote>由于对新冠病毒奥密克戎变种及其对全球经济复苏影响的担忧挥之不去，美国股指期货周三难以把握方向，在前一天的反弹后有所降温。</blockquote></p><p> At 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&amp;P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.</p><p><blockquote>截至美国东部时间上午8:00，道琼斯电子迷你指数上涨42点，涨幅0.12%，标普500电子迷你指数上涨1.25点，涨幅0.03%，纳斯达克100电子迷你指数下跌7.75点，涨幅0.05%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/512d5749bf54708c7063a6e721fa99f2\" tg-width=\"960\" tg-height=\"329\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p><p><blockquote><p class=\"t-img-caption\"><span>*来源自Tiger Trade，美国东部时间08:00</span></p></blockquote></p><p> Wall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&amp;P 500 index&nbsp;is up roughly 24% in 2021.</p><p><blockquote>华尔街主要股指周二收盘大幅上涨，但今年最后两周交易中几乎没有推动市场的催化剂和清淡的交易量被视为加剧了波动性。标普500指数在2021年上涨了约24%。</blockquote></p><p> Investors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.</p><p><blockquote>在德国、苏格兰、爱尔兰、葡萄牙、荷兰和南韩重新实施封锁或其他限制措施后，投资者寻找奥密克戎变体的最新消息。</blockquote></p><p> <b>Stocks making the biggest moves in the premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <a href=\"https://laohu8.com/S/KMX\">CarMax</a> (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.</p><p><blockquote><a href=\"https://laohu8.com/S/KMX\">CarMax</a>(KMX)-CarMax最近一个季度的营收和利润超出预期，并且可比经销商销售额也高于分析师预测，该汽车零售商的股价在盘前交易中上涨5.1%。</blockquote></p><p> <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.</p><p><blockquote><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>(TSLA)-特斯拉股价在盘前上涨3.4%，此前首席执行官Elon Musk表示，他现在已经出售了足够的股票，以达到出售10%股份的目标。然而，在那段时间里，由于行使期权，马斯克实际上已经增持了特斯拉。</blockquote></p><p> <a href=\"https://laohu8.com/S/BB\">BlackBerry</a> (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.</p><p><blockquote><a href=\"https://laohu8.com/S/BB\">黑莓</a>(BB)-黑莓报告调整后季度实现盈亏平衡，而分析师预测为每股亏损7美分。得益于对网络安全产品的强劲需求，这家通信软件制造商的收入也超出了预期，但当前季度对这些产品的预测低于一些分析师的预期。</blockquote></p><p> <a href=\"https://laohu8.com/S/CAT\">Caterpillar</a> (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.</p><p><blockquote><a href=\"https://laohu8.com/S/CAT\">毛虫</a>(CAT)-伯恩斯坦将重型设备制造商卡特彼勒的股票评级从“与大盘持平”上调至“跑赢大盘”后，该公司盘前上涨1.6%。伯恩斯坦表示，对机械升级周期将于2022年结束的担忧有些过头了。</blockquote></p><p> <a href=\"https://laohu8.com/S/CAMP\">CalAmp</a> (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.</p><p><blockquote><a href=\"https://laohu8.com/S/CAMP\">CalAmp</a>（CAMP）——CalAmp最近一个季度调整后每股亏损8美分，令此前预期每股盈利8美分的分析师感到惊讶。这家无线数据通信产品和软件制造商的收入也低于预期，零部件短缺是影响其业绩的关键因素。CalAmp在盘前股价暴跌15.7%。</blockquote></p><p> <a href=\"https://laohu8.com/S/BABA\">Alibaba</a> (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.</p><p><blockquote><a href=\"https://laohu8.com/S/BABA\">阿里巴巴-SW</a>（阿里巴巴）——大西洋股票将这家中国电子商务公司的股票评级从“跑赢大盘”下调至“中性”后，阿里巴巴-SW股价盘前下跌4%。该公司担心阿里巴巴-SW购物平台天猫和淘宝的业绩短期内不会改善。</blockquote></p><p> <a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a> (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.</p><p><blockquote><a href=\"https://laohu8.com/S/DRI\">达顿餐厅</a>(DRI)-Stifel Financial将Darden Restaurants的评级从“持有”上调至“买入”，这表明Olive Garden母公司上周公布了乐观的季度业绩。该报告发布后，该股下跌，但Stifel认为，这是由首席执行官Gene Lee将于5月退休的消息推动的。达顿在盘前交易中上涨1.1%。</blockquote></p><p> <a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a> (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.</p><p><blockquote><a href=\"https://laohu8.com/S/WSM\">威廉姆斯-索诺玛</a>(WSM)——Loop Capital将Williams-Sonoma的评级从“持有”上调至“买入”，该公司认为这家家居用品零售商拥有“顶级”品牌，疫情带来的推动力将持续到2022年。</blockquote></p><p> <a href=\"https://laohu8.com/S/COIN\">Coinbase Global, Inc.</a> (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.</p><p><blockquote><a href=\"https://laohu8.com/S/COIN\">比特币基地全球公司。</a>（COIN）-加密货币基础设施公司在奥本海默被评为2022年的“首选”，这表明数字资产正在加速进入主流。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday<blockquote>周三美国市场开盘前的顶线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-22 21:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.</p><p><blockquote>由于对新冠病毒奥密克戎变种及其对全球经济复苏影响的担忧挥之不去，美国股指期货周三难以把握方向，在前一天的反弹后有所降温。</blockquote></p><p> At 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&amp;P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.</p><p><blockquote>截至美国东部时间上午8:00，道琼斯电子迷你指数上涨42点，涨幅0.12%，标普500电子迷你指数上涨1.25点，涨幅0.03%，纳斯达克100电子迷你指数下跌7.75点，涨幅0.05%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/512d5749bf54708c7063a6e721fa99f2\" tg-width=\"960\" tg-height=\"329\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p><p><blockquote><p class=\"t-img-caption\"><span>*来源自Tiger Trade，美国东部时间08:00</span></p></blockquote></p><p> Wall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&amp;P 500 index&nbsp;is up roughly 24% in 2021.</p><p><blockquote>华尔街主要股指周二收盘大幅上涨，但今年最后两周交易中几乎没有推动市场的催化剂和清淡的交易量被视为加剧了波动性。标普500指数在2021年上涨了约24%。</blockquote></p><p> Investors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.</p><p><blockquote>在德国、苏格兰、爱尔兰、葡萄牙、荷兰和南韩重新实施封锁或其他限制措施后，投资者寻找奥密克戎变体的最新消息。</blockquote></p><p> <b>Stocks making the biggest moves in the premarket:</b></p><p><blockquote><b>盘前涨幅最大的股票：</b></blockquote></p><p> <a href=\"https://laohu8.com/S/KMX\">CarMax</a> (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.</p><p><blockquote><a href=\"https://laohu8.com/S/KMX\">CarMax</a>(KMX)-CarMax最近一个季度的营收和利润超出预期，并且可比经销商销售额也高于分析师预测，该汽车零售商的股价在盘前交易中上涨5.1%。</blockquote></p><p> <a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.</p><p><blockquote><a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>(TSLA)-特斯拉股价在盘前上涨3.4%，此前首席执行官Elon Musk表示，他现在已经出售了足够的股票，以达到出售10%股份的目标。然而，在那段时间里，由于行使期权，马斯克实际上已经增持了特斯拉。</blockquote></p><p> <a href=\"https://laohu8.com/S/BB\">BlackBerry</a> (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.</p><p><blockquote><a href=\"https://laohu8.com/S/BB\">黑莓</a>(BB)-黑莓报告调整后季度实现盈亏平衡，而分析师预测为每股亏损7美分。得益于对网络安全产品的强劲需求，这家通信软件制造商的收入也超出了预期，但当前季度对这些产品的预测低于一些分析师的预期。</blockquote></p><p> <a href=\"https://laohu8.com/S/CAT\">Caterpillar</a> (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.</p><p><blockquote><a href=\"https://laohu8.com/S/CAT\">毛虫</a>(CAT)-伯恩斯坦将重型设备制造商卡特彼勒的股票评级从“与大盘持平”上调至“跑赢大盘”后，该公司盘前上涨1.6%。伯恩斯坦表示，对机械升级周期将于2022年结束的担忧有些过头了。</blockquote></p><p> <a href=\"https://laohu8.com/S/CAMP\">CalAmp</a> (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.</p><p><blockquote><a href=\"https://laohu8.com/S/CAMP\">CalAmp</a>（CAMP）——CalAmp最近一个季度调整后每股亏损8美分，令此前预期每股盈利8美分的分析师感到惊讶。这家无线数据通信产品和软件制造商的收入也低于预期，零部件短缺是影响其业绩的关键因素。CalAmp在盘前股价暴跌15.7%。</blockquote></p><p> <a href=\"https://laohu8.com/S/BABA\">Alibaba</a> (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.</p><p><blockquote><a href=\"https://laohu8.com/S/BABA\">阿里巴巴-SW</a>（阿里巴巴）——大西洋股票将这家中国电子商务公司的股票评级从“跑赢大盘”下调至“中性”后，阿里巴巴-SW股价盘前下跌4%。该公司担心阿里巴巴-SW购物平台天猫和淘宝的业绩短期内不会改善。</blockquote></p><p> <a href=\"https://laohu8.com/S/DRI\">Darden Restaurants</a> (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.</p><p><blockquote><a href=\"https://laohu8.com/S/DRI\">达顿餐厅</a>(DRI)-Stifel Financial将Darden Restaurants的评级从“持有”上调至“买入”，这表明Olive Garden母公司上周公布了乐观的季度业绩。该报告发布后，该股下跌，但Stifel认为，这是由首席执行官Gene Lee将于5月退休的消息推动的。达顿在盘前交易中上涨1.1%。</blockquote></p><p> <a href=\"https://laohu8.com/S/WSM\">Williams-Sonoma</a> (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.</p><p><blockquote><a href=\"https://laohu8.com/S/WSM\">威廉姆斯-索诺玛</a>(WSM)——Loop Capital将Williams-Sonoma的评级从“持有”上调至“买入”，该公司认为这家家居用品零售商拥有“顶级”品牌，疫情带来的推动力将持续到2022年。</blockquote></p><p> <a href=\"https://laohu8.com/S/COIN\">Coinbase Global, Inc.</a> (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.</p><p><blockquote><a href=\"https://laohu8.com/S/COIN\">比特币基地全球公司。</a>（COIN）-加密货币基础设施公司在奥本海默被评为2022年的“首选”，这表明数字资产正在加速进入主流。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158577227","content_text":"U.S. stock index futures struggled for direction on Wednesday, cooling off after a day-earlier rally, as worries lingered about the new Omicron variant of the coronavirus and its impact on global economic recovery.\nAt 8:00 a.m. ET, Dow E-minis were up 42 points, or 0.12%, S&P 500 E-minis were up 1.25 points, or 0.03% and Nasdaq 100 E-minis were down 7.75 points, or 0.05%.\n*Source From Tiger Trade, EST 08:00\nWall Street's main indexes ended with hefty gains on Tuesday, but few market-moving catalysts and thin volumes in the last two weeks of trading this year are seen aiding higher volatility. The S&P 500 index is up roughly 24% in 2021.\nInvestors looked for updates on the Omicron variant after Germany, Scotland, Ireland, Portugal, the Netherlands and South Korea re-imposed lockdowns or other curbs.\nStocks making the biggest moves in the premarket:\nCarMax (KMX) – The auto retailer’s stock jumped 5.1% in premarket trading after CarMax beat estimates on the top and bottom lines for its latest quarter, as well as posting comparable dealer sales that were above analyst forecasts.\nTesla Motors (TSLA) – Tesla shares rose 3.4% in the premarket after CEO Elon Musk said he has now sold enough stock to reach his goal of selling 10% of his shares. Over that time, however, Musk has actually increased his holdings in Tesla due to the exercising of options.\nBlackBerry (BB) – BlackBerry reported a breakeven quarter, on an adjusted basis, compared with analyst forecasts of a 7 cents per share loss. The communications software maker also saw revenue beat estimates, helped by strong demand for cybersecurity products, but current quarter forecasts for those products is shy of some analyst estimates.\nCaterpillar (CAT) – Caterpillar rose 1.6% in the premarket after Bernstein upgraded the heavy equipment maker’s stock to “outperform” from “market perform.” Bernstein said concerns about a machinery upgrade cycle ending in 2022 are overdone.\nCalAmp (CAMP) – CalAmp lost an adjusted 8 cents per share for its latest quarter, surprising analysts who had expected a profit of 8 cents per share. The maker of wireless data communications products and software also saw revenue fall short of forecasts, with component shortages a key factor impacting its results. CalAmp plunged 15.7% in premarket action.\nAlibaba (BABA) – Alibaba shares fell 4% in the premarket after Atlantic Equities downgraded the Chinese e-commerce company’s stock to “neutral” from “overweight.” The firm cites concerns that Alibaba shopping platforms Tmall and Taobao won’t see improvement in their performances in the near term.\nDarden Restaurants (DRI) – Darden Restaurants was upgraded to “buy” from “hold” at Stifel Financial, which pointed to the Olive Garden parent’s upbeat quarterly results last week. The stock had fallen after that report, but Stifel believes that was driven by the announcement that CEO Gene Lee will retire in May. Darden added 1.1% in premarket trading.\nWilliams-Sonoma (WSM) – Williams-Sonoma was upgraded to “buy” from “hold” at Loop Capital, which thinks the household products retailer has a “premier” brand and that the tailwinds provided by the pandemic will continue well into 2022.\nCoinbase Global, Inc. (COIN) – The cryptocurrency infrastructure company was named a “top pick” for 2022 at Oppenheimer, which pointed to an accelerating move into the mainstream for digital assets.","news_type":1,"symbols_score_info":{"YMmain":0,".SPX":0,"ESmain":0,".DJI":0,"NQmain":0,".IXIC":0}},"isVote":1,"tweetType":1,"viewCount":2975,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693630291,"gmtCreate":1640011524242,"gmtModify":1640011524564,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693630291","repostId":"1100495818","repostType":4,"repost":{"id":"1100495818","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640010925,"share":"https://www.laohu8.com/m/news/1100495818?lang=zh_CN&edition=full","pubTime":"2021-12-20 22:35","market":"us","language":"en","title":"Novavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax的新冠疫苗被推荐获得欧盟批准，股价上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1100495818","media":"Tiger Newspress","summary":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use o","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p><p><blockquote>Novavax股价早盘上涨5%。欧盟药品监管机构周一批准在18岁及以上人群中使用美国Novavax的COVID-19疫苗，随着奥密克戎冠状病毒变种的传播，为该地区第五次冠状病毒注射铺平了道路。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax的新冠疫苗被推荐获得欧盟批准，股价上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Climbs as Its Covid Vaccine Recommended for EU Approval<blockquote>Novavax的新冠疫苗被推荐获得欧盟批准，股价上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-20 22:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;5%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2b0834cd3440742caa0135d7d6be7ec2\" tg-width=\"708\" tg-height=\"595\" width=\"100%\" height=\"auto\">The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.</p><p><blockquote>Novavax股价早盘上涨5%。欧盟药品监管机构周一批准在18岁及以上人群中使用美国Novavax的COVID-19疫苗，随着奥密克戎冠状病毒变种的传播，为该地区第五次冠状病毒注射铺平了道路。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100495818","content_text":"Novavax shares rose 5% in early trading.The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":2531,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699234776,"gmtCreate":1639806304859,"gmtModify":1639806305159,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Stock market gogoogoogogoo","listText":"Stock market gogoogoogogoo","text":"Stock market gogoogoogogoo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699234776","isVote":1,"tweetType":1,"viewCount":2887,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690876947,"gmtCreate":1639659446625,"gmtModify":1639659446920,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Gogogo stock market flyyyy","listText":"Gogogo stock market flyyyy","text":"Gogogo stock market flyyyy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690876947","isVote":1,"tweetType":1,"viewCount":2166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602600254,"gmtCreate":1639011039052,"gmtModify":1639011039306,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602600254","repostId":"2190969538","repostType":2,"repost":{"id":"2190969538","kind":"highlight","pubTimestamp":1638999237,"share":"https://www.laohu8.com/m/news/2190969538?lang=zh_CN&edition=full","pubTime":"2021-12-09 05:33","market":"fut","language":"zh","title":"外媒头条：小摩最新预测！明年全球经济将全面复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2190969538","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、摩根大通：2022年全球经济将全面复苏\n\n\n2、辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗\n\n\n3、美银：标普500指数实","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>：2022年全球经济将全面复苏</b>\n</blockquote>\n<blockquote>\n <b>2、<a href=\"https://laohu8.com/S/PFE\">辉瑞</a>CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b>\n</blockquote>\n<blockquote>\n <b>3、美银：标普500指数实际盈利收益率处于1947年以来最低水平</b>\n</blockquote>\n<blockquote>\n <b>4、美国商务部长：对欧盟数字法案的影响感到担忧</b>\n</blockquote>\n<blockquote>\n <b>5、等待芯片交付的时间再度拉长 缺货现象料难改善</b>\n</blockquote>\n<blockquote>\n <b>6、英国首相恢复居家工作建议 以遏制omicron传播</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/c73d5ba64db8e6f5394e17bed1d68026\" tg-width=\"365\" tg-height=\"259\" referrerpolicy=\"no-referrer\"></p>\n<p><b><a href=\"https://laohu8.com/S/JPM\">摩根大通</a>：2022年全球经济将全面复苏</b></p>\n<p>美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。</p>\n<p>该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。</p>\n<p>摩根大通首席全球市场策略师兼全球研究联席主管Marko Kolanovic表示，该行预计，到2022年底，标普500指数将上涨近8%至5050点，新兴市场股票将飙升18%，10年期美国债收益率升至2.25%。</p>\n<p>Kolanovic称：“我们认为，2022年将是全球全面复苏、疫情结束以及恢复到疫情爆发前正常经济和市场状况的一年。”</p>\n<p><img src=\"https://static.tigerbbs.com/f64958459d8e15362eda127e159e2b5e\" tg-width=\"550\" tg-height=\"309\" referrerpolicy=\"no-referrer\"></p>\n<p><b><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>CEO：因omicron的出现 可能要比预期更早接种第四针疫苗</b></p>\n<p>辉瑞（Pfizer）首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。</p>\n<p>辉瑞和BioNTech周三上午公布了一项初步实验室研究的结果，该结果表明，第三针疫苗可有效对抗omicron变体，而最初的两剂疫苗在抵御新毒株的能力方面显著下降。然而两家公司表示，两针疫苗可能仍然可以防止因omicron引起的重症。</p>\n<p>Bourla指出，该公司的初步研究是基于实验室创建的该变体的合成副本，需要从针对真实病毒的测试中获得更多数据。Bourla表示，真实情况的结果将更加准确，预计将在未来两周内公布。</p>\n<p>“当我们看到真实情况的数据时，将会确定第三剂是否能很好地抵御omicron以及持续多长时间。第二点，我认为我们需要第四剂加强针，”Bourla称。</p>\n<p>Bourla此前预计，在第三针注射后12个月，需要注射第四针。 “对于omicron，我们需要继续观察，因为我们掌握的信息很少。我们可能需要更快，”他说。</p>\n<p><img src=\"https://static.tigerbbs.com/f7f315f864fdab28ae7ded4de244515e\" tg-width=\"550\" tg-height=\"361\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美银：标普500指数实际盈利收益率处于1947年以来最低水平</b></p>\n<p><a href=\"https://laohu8.com/S/BAC\">美国银行</a>策略师说，美国股市的实际盈利收益率已经降至杜鲁门就任总统、冷战刚刚开始以来的最低水平。</p>\n<p>Savita Subramanian牵头的策略师在周三的一份报告中写道，标普500指数目前的实际盈利收益率为-2.9%，意味着如果公司业绩不持续增长，那么投资者经通胀调整后将损失2.9%。“上次实际盈利收益率为负还是1947年。”</p>\n<p>策略师们表示，前四次实际盈利收益率为负的时候，均出现了熊市。他们建议投资者在能源、金融和房地产等抗通胀板块寻求避险。他们表示，对未来12个月通胀率将从6.2%降至2.5%的预期可能过于乐观，这代表着40年来最急速的通胀下降。</p>\n<p><a href=\"https://laohu8.com/S/BAC\">美国银行</a>一直看跌美国和欧洲股市，尽管两边主要指数最近几个月都创历史新高。在新冠病毒omicron变异株引发市场短暂下跌之后，标普500指数已经反弹并徘徊在纪录高位附近。</p>\n<p><img src=\"https://static.tigerbbs.com/9b554496205f305c148e99e907890134\" tg-width=\"550\" tg-height=\"376\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国商务部长：对欧盟数字法案的影响感到担忧</b></p>\n<p>美国商务部长雷蒙多表示，美国感到“严重关切”的是，欧盟的数字市场法案和数字服务法案会过度地影响总部在美国的科技企业及其充分服务欧盟客户、捍卫安全和隐私标准的能力。</p>\n<p>美国鼓励欧盟在推进立法程序之际，听取利益攸关方对这些法案的关切。</p>\n<p>雷蒙多以视频连线方式在美国商会的跨<a href=\"https://laohu8.com/S/600558\">大西洋</a>商业工作峰会上表示。</p>\n<p>雷蒙多指出，美国意识到，欧盟希望利用这些法案来营造公平、透明和安全的数字空间。</p>\n<p>她说，拜登政府认为敲定加强版的欧盟-美国“隐私盾”是第一要务，她仍然在积极地参与谈判。</p>\n<p><img src=\"https://static.tigerbbs.com/fb8e158634830a8680488986098a8d56\" tg-width=\"550\" tg-height=\"274\" referrerpolicy=\"no-referrer\"></p>\n<p><b>等待芯片交付的时间再度拉长 缺货现象料难改善</b></p>\n<p>芯片交付时间在11月份再次拉长，浇灭了令许多行业蒙受损失的缺货现象终见天日的希望。</p>\n<p>Susquehanna Financial Group的研究显示，备受关注的前置时间上个月比10月份增加了四天，达到约22.3周。这一等待时间创下了该公司2017年开始跟踪数据以来的最长纪录。</p>\n<p>对需要更多芯片的行业来说是这无疑是个挫折。包括苹果公司和<a href=\"https://laohu8.com/S/F\">福特汽车</a>在内的各类企业都抱怨无法满足客户对产品的需求，而同时成本也在上升。芯片交付时间增速在10月曾出现放缓，燃起了认为形势正在改善的乐观情绪。</p>\n<p>“虽然增长比最近几个月的大多数时间要短，但我们本来是希望出现明显逆转的，” Susquehanna分析师Chris Rolland在研究报告中表示。</p>\n<p><img src=\"https://static.tigerbbs.com/d37088174440cde2b2960461fa23ce07\" tg-width=\"550\" tg-height=\"367\" referrerpolicy=\"no-referrer\"></p>\n<p><b>英国首相恢复居家工作建议 以遏制omicron传播</b></p>\n<p>英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。</p>\n<p>“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。</p>\n<p>即便在omicron出现前，英国单日新增新冠病例已经连续数月保持较高水平，因此有警告称这个新毒株将使医院系统不堪重负。在约翰逊宣布启动B计划前，苏格兰、威尔士和北爱尔兰已经实施了更严格的防疫限制。</p>\n<p>虽然新规远没有达到先前实施封锁时的严厉程度，但仍代表着重大调整，对约翰逊而言存在政治风险。约翰逊政府原本希望通过加快加强针的接种，避免在圣诞节期间推出新的限制措施。</p>","source":"XLCJ","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：小摩最新预测！明年全球经济将全面复苏</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：小摩最新预测！明年全球经济将全面复苏\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-09 05:33 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-12-09/doc-ikyamrmy7749780.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、摩根大通：2022年全球经济将全面复苏\n\n\n2、辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗\n\n\n3、美银：标普500指数实际盈利收益率处于1947年以来最低水平\n\n\n4、美国商务部长：对欧盟数字法案的影响感到担忧\n\n\n5、等待芯片交付的时间再度拉长 缺货现象料难改善\n\n\n6、英国首相恢复居家工作建议 以遏制omicron...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-12-09/doc-ikyamrmy7749780.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","relate_stocks":{"BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","JPM":"摩根大通","BK4566":"资本集团","BK4207":"综合性银行",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","BK4533":"AQR资本管理(全球第二大对冲基金)",".DJI":"道琼斯","BK4504":"桥水持仓","PFE":"辉瑞"},"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-12-09/doc-ikyamrmy7749780.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190969538","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、摩根大通：2022年全球经济将全面复苏\n\n\n2、辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗\n\n\n3、美银：标普500指数实际盈利收益率处于1947年以来最低水平\n\n\n4、美国商务部长：对欧盟数字法案的影响感到担忧\n\n\n5、等待芯片交付的时间再度拉长 缺货现象料难改善\n\n\n6、英国首相恢复居家工作建议 以遏制omicron传播\n\n\n摩根大通：2022年全球经济将全面复苏\n美国投行摩根大通周三预测，2022年将标志着新冠疫情的结束，全球经济将全面复苏。\n该行在2022年的展望报告中称，新的疫苗和疗法将引发“强劲的周期性复苏、全球流动性的回归以及消费者被压抑需求的释放”。\n摩根大通首席全球市场策略师兼全球研究联席主管Marko Kolanovic表示，该行预计，到2022年底，标普500指数将上涨近8%至5050点，新兴市场股票将飙升18%，10年期美国债收益率升至2.25%。\nKolanovic称：“我们认为，2022年将是全球全面复苏、疫情结束以及恢复到疫情爆发前正常经济和市场状况的一年。”\n\n辉瑞CEO：因omicron的出现 可能要比预期更早接种第四针疫苗\n辉瑞（Pfizer）首席执行官Albert Bourla周三表示，在初步研究表明omicron变体会破坏新冠疫苗产生的保护性抗体后，人们可能需要比预期更早地接种第四针新冠疫苗。\n辉瑞和BioNTech周三上午公布了一项初步实验室研究的结果，该结果表明，第三针疫苗可有效对抗omicron变体，而最初的两剂疫苗在抵御新毒株的能力方面显著下降。然而两家公司表示，两针疫苗可能仍然可以防止因omicron引起的重症。\nBourla指出，该公司的初步研究是基于实验室创建的该变体的合成副本，需要从针对真实病毒的测试中获得更多数据。Bourla表示，真实情况的结果将更加准确，预计将在未来两周内公布。\n“当我们看到真实情况的数据时，将会确定第三剂是否能很好地抵御omicron以及持续多长时间。第二点，我认为我们需要第四剂加强针，”Bourla称。\nBourla此前预计，在第三针注射后12个月，需要注射第四针。 “对于omicron，我们需要继续观察，因为我们掌握的信息很少。我们可能需要更快，”他说。\n\n美银：标普500指数实际盈利收益率处于1947年以来最低水平\n美国银行策略师说，美国股市的实际盈利收益率已经降至杜鲁门就任总统、冷战刚刚开始以来的最低水平。\nSavita Subramanian牵头的策略师在周三的一份报告中写道，标普500指数目前的实际盈利收益率为-2.9%，意味着如果公司业绩不持续增长，那么投资者经通胀调整后将损失2.9%。“上次实际盈利收益率为负还是1947年。”\n策略师们表示，前四次实际盈利收益率为负的时候，均出现了熊市。他们建议投资者在能源、金融和房地产等抗通胀板块寻求避险。他们表示，对未来12个月通胀率将从6.2%降至2.5%的预期可能过于乐观，这代表着40年来最急速的通胀下降。\n美国银行一直看跌美国和欧洲股市，尽管两边主要指数最近几个月都创历史新高。在新冠病毒omicron变异株引发市场短暂下跌之后，标普500指数已经反弹并徘徊在纪录高位附近。\n\n美国商务部长：对欧盟数字法案的影响感到担忧\n美国商务部长雷蒙多表示，美国感到“严重关切”的是，欧盟的数字市场法案和数字服务法案会过度地影响总部在美国的科技企业及其充分服务欧盟客户、捍卫安全和隐私标准的能力。\n美国鼓励欧盟在推进立法程序之际，听取利益攸关方对这些法案的关切。\n雷蒙多以视频连线方式在美国商会的跨大西洋商业工作峰会上表示。\n雷蒙多指出，美国意识到，欧盟希望利用这些法案来营造公平、透明和安全的数字空间。\n她说，拜登政府认为敲定加强版的欧盟-美国“隐私盾”是第一要务，她仍然在积极地参与谈判。\n\n等待芯片交付的时间再度拉长 缺货现象料难改善\n芯片交付时间在11月份再次拉长，浇灭了令许多行业蒙受损失的缺货现象终见天日的希望。\nSusquehanna Financial Group的研究显示，备受关注的前置时间上个月比10月份增加了四天，达到约22.3周。这一等待时间创下了该公司2017年开始跟踪数据以来的最长纪录。\n对需要更多芯片的行业来说是这无疑是个挫折。包括苹果公司和福特汽车在内的各类企业都抱怨无法满足客户对产品的需求，而同时成本也在上升。芯片交付时间增速在10月曾出现放缓，燃起了认为形势正在改善的乐观情绪。\n“虽然增长比最近几个月的大多数时间要短，但我们本来是希望出现明显逆转的，” Susquehanna分析师Chris Rolland在研究报告中表示。\n\n英国首相恢复居家工作建议 以遏制omicron传播\n英国首相鲍里斯·约翰逊收紧防疫规定以遏制变异毒株omicron的传播，建议人们在家工作，并强制要求在大型公共场所使用“疫苗护照”。\n“越来越明显的是，omicron增长速度远快于德尔塔，”约翰逊在周三电视新闻发布会上宣布了英格兰地区的新防疫措施。他表示，“实施B计划是合适而负责任的做法”。\n即便在omicron出现前，英国单日新增新冠病例已经连续数月保持较高水平，因此有警告称这个新毒株将使医院系统不堪重负。在约翰逊宣布启动B计划前，苏格兰、威尔士和北爱尔兰已经实施了更严格的防疫限制。\n虽然新规远没有达到先前实施封锁时的严厉程度，但仍代表着重大调整，对约翰逊而言存在政治风险。约翰逊政府原本希望通过加快加强针的接种，避免在圣诞节期间推出新的限制措施。","news_type":1,"symbols_score_info":{"JPM":0.9,"PFE":0.9,".SPX":0.9,".DJI":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":3608,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602308439,"gmtCreate":1638967201321,"gmtModify":1638967201577,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602308439","repostId":"1189850079","repostType":4,"repost":{"id":"1189850079","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638954825,"share":"https://www.laohu8.com/m/news/1189850079?lang=zh_CN&edition=full","pubTime":"2021-12-08 17:13","market":"us","language":"en","title":"Apple stock climbed more than 1% in premarket trading<blockquote>苹果股价在盘前交易中上涨超过1%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189850079","media":"Tiger Newspress","summary":"Apple stock climbed more than 1% in premarket trading on the report that Apple told suppliers to rea","content":"<p>Apple stock climbed more than 1% in premarket trading&nbsp;on&nbsp;the&nbsp;report&nbsp;that&nbsp;Apple told suppliers to reaccelerate their production of the iPhone for November, December and January.</p><p><blockquote>有报道称苹果要求供应商重新加快11月、12月和1月的iPhone生产，苹果股价在盘前交易中上涨超过1%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6bbd124a3954ad6191a98fd9b5a2a1c1\" tg-width=\"853\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> In September and October, production of the iPhone 13 range fell 20% short of previous plans, people directly involved in its supply chain told Nikkei. This was even after Apple prioritized all the necessary components for the latest flagship smartphone -- the company's most important revenue source -- at the expense of other products such as iPads and older generations such as the iPhone 12 and iPhone SE.</p><p><blockquote>直接参与供应链的人士告诉《日经新闻》，9月和10月，iPhone 13系列的产量比之前的计划下降了20%。即使苹果优先考虑了最新旗舰智能手机（该公司最重要的收入来源）的所有必要组件，而牺牲了iPad等其他产品以及iPhone 12和iPhone SE等老一代产品。</blockquote></p><p> Over the same period, the reallocation of the shared components squeezed iPad assembly even more, leading to about 50% less production volume than planned, while the production forecast for older generations of iPhones also dropped around 25%, Nikkei heard from multiple sources. The situation for iPads and older iPhones was not much improved by November.</p><p><blockquote>日经新闻从多个消息来源获悉，同一时期，共享组件的重新分配进一步挤压了iPad组装，导致产量比计划减少约50%，而老一代iPhone的产量预测也下降了约25%。到11月份，iPads和旧款iPhones的情况并没有太大改善。</blockquote></p><p> Apple was forced to scale back its total production goal for 2021, people briefed on the matter told Nikkei. At the beginning of December, the company was on course to make only about 83 million to 85 million units in the iPhone 13 range before the end of the year, falling short of the ambitious goal of up to 95 million units it had set to capture the first shopping season after Western economies reopened from COVID-19 lockdowns. Overall, despite reaccelerating production in November, Apple was still falling about 15 million units short of its aim to build 230 million iPhones in total this year, an ambitious goal set at the beginning of 2021, sources said.</p><p><blockquote>知情人士告诉《日经新闻》，苹果被迫缩减2021年的总产量目标。12月初，该公司计划在年底前仅生产约8300万至8500万部iPhone 13系列，未达到其设定的最多9500万部的雄心勃勃的目标。西方经济体从COVID-19封锁中重新开放后的第一个购物季。消息人士称，总体而言，尽管11月份重新加速了生产，但苹果仍比今年总共生产2.3亿部iPhone的目标少了约1500万部，这是2021年初设定的一个雄心勃勃的目标。</blockquote></p><p> Apple told suppliers to reaccelerate their production of the iPhone for November, December and January, after stumbling for the past few months, sources said. Communications in the past two days indicate it hopes to get more than 5 million units closer to its original goal than it expected at the beginning of December.&nbsp;\"Demand for the iPhone 13 range should be able to extend until January next year, as Apple does not want to waste the opportunity to take more ground from Huawei, while Samsung and Xiaomi are suffering from chips and component mismatches,\" said a source&nbsp;with direct knowledge of the conversations.</p><p><blockquote>消息人士称，在过去几个月陷入困境后，苹果告诉供应商重新加快11月、12月和1月的iPhone生产。过去两天的沟通表明，它希望比12月初的预期更接近最初的目标500万部以上。一位直接了解对话的消息人士表示：“对iPhone 13系列的需求应该能够延长到明年1月，因为苹果不想浪费从华为手中夺取更多地盘的机会，而三星和小米正遭受芯片和组件不匹配的困扰。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple stock climbed more than 1% in premarket trading<blockquote>苹果股价在盘前交易中上涨超过1%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple stock climbed more than 1% in premarket trading<blockquote>苹果股价在盘前交易中上涨超过1%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-08 17:13</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple stock climbed more than 1% in premarket trading&nbsp;on&nbsp;the&nbsp;report&nbsp;that&nbsp;Apple told suppliers to reaccelerate their production of the iPhone for November, December and January.</p><p><blockquote>有报道称苹果要求供应商重新加快11月、12月和1月的iPhone生产，苹果股价在盘前交易中上涨超过1%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/6bbd124a3954ad6191a98fd9b5a2a1c1\" tg-width=\"853\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> In September and October, production of the iPhone 13 range fell 20% short of previous plans, people directly involved in its supply chain told Nikkei. This was even after Apple prioritized all the necessary components for the latest flagship smartphone -- the company's most important revenue source -- at the expense of other products such as iPads and older generations such as the iPhone 12 and iPhone SE.</p><p><blockquote>直接参与供应链的人士告诉《日经新闻》，9月和10月，iPhone 13系列的产量比之前的计划下降了20%。即使苹果优先考虑了最新旗舰智能手机（该公司最重要的收入来源）的所有必要组件，而牺牲了iPad等其他产品以及iPhone 12和iPhone SE等老一代产品。</blockquote></p><p> Over the same period, the reallocation of the shared components squeezed iPad assembly even more, leading to about 50% less production volume than planned, while the production forecast for older generations of iPhones also dropped around 25%, Nikkei heard from multiple sources. The situation for iPads and older iPhones was not much improved by November.</p><p><blockquote>日经新闻从多个消息来源获悉，同一时期，共享组件的重新分配进一步挤压了iPad组装，导致产量比计划减少约50%，而老一代iPhone的产量预测也下降了约25%。到11月份，iPads和旧款iPhones的情况并没有太大改善。</blockquote></p><p> Apple was forced to scale back its total production goal for 2021, people briefed on the matter told Nikkei. At the beginning of December, the company was on course to make only about 83 million to 85 million units in the iPhone 13 range before the end of the year, falling short of the ambitious goal of up to 95 million units it had set to capture the first shopping season after Western economies reopened from COVID-19 lockdowns. Overall, despite reaccelerating production in November, Apple was still falling about 15 million units short of its aim to build 230 million iPhones in total this year, an ambitious goal set at the beginning of 2021, sources said.</p><p><blockquote>知情人士告诉《日经新闻》，苹果被迫缩减2021年的总产量目标。12月初，该公司计划在年底前仅生产约8300万至8500万部iPhone 13系列，未达到其设定的最多9500万部的雄心勃勃的目标。西方经济体从COVID-19封锁中重新开放后的第一个购物季。消息人士称，总体而言，尽管11月份重新加速了生产，但苹果仍比今年总共生产2.3亿部iPhone的目标少了约1500万部，这是2021年初设定的一个雄心勃勃的目标。</blockquote></p><p> Apple told suppliers to reaccelerate their production of the iPhone for November, December and January, after stumbling for the past few months, sources said. Communications in the past two days indicate it hopes to get more than 5 million units closer to its original goal than it expected at the beginning of December.&nbsp;\"Demand for the iPhone 13 range should be able to extend until January next year, as Apple does not want to waste the opportunity to take more ground from Huawei, while Samsung and Xiaomi are suffering from chips and component mismatches,\" said a source&nbsp;with direct knowledge of the conversations.</p><p><blockquote>消息人士称，在过去几个月陷入困境后，苹果告诉供应商重新加快11月、12月和1月的iPhone生产。过去两天的沟通表明，它希望比12月初的预期更接近最初的目标500万部以上。一位直接了解对话的消息人士表示：“对iPhone 13系列的需求应该能够延长到明年1月，因为苹果不想浪费从华为手中夺取更多地盘的机会，而三星和小米正遭受芯片和组件不匹配的困扰。”</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189850079","content_text":"Apple stock climbed more than 1% in premarket trading on the report that Apple told suppliers to reaccelerate their production of the iPhone for November, December and January.\n\nIn September and October, production of the iPhone 13 range fell 20% short of previous plans, people directly involved in its supply chain told Nikkei. This was even after Apple prioritized all the necessary components for the latest flagship smartphone -- the company's most important revenue source -- at the expense of other products such as iPads and older generations such as the iPhone 12 and iPhone SE.\nOver the same period, the reallocation of the shared components squeezed iPad assembly even more, leading to about 50% less production volume than planned, while the production forecast for older generations of iPhones also dropped around 25%, Nikkei heard from multiple sources. The situation for iPads and older iPhones was not much improved by November.\nApple was forced to scale back its total production goal for 2021, people briefed on the matter told Nikkei. At the beginning of December, the company was on course to make only about 83 million to 85 million units in the iPhone 13 range before the end of the year, falling short of the ambitious goal of up to 95 million units it had set to capture the first shopping season after Western economies reopened from COVID-19 lockdowns. Overall, despite reaccelerating production in November, Apple was still falling about 15 million units short of its aim to build 230 million iPhones in total this year, an ambitious goal set at the beginning of 2021, sources said.\nApple told suppliers to reaccelerate their production of the iPhone for November, December and January, after stumbling for the past few months, sources said. Communications in the past two days indicate it hopes to get more than 5 million units closer to its original goal than it expected at the beginning of December. \"Demand for the iPhone 13 range should be able to extend until January next year, as Apple does not want to waste the opportunity to take more ground from Huawei, while Samsung and Xiaomi are suffering from chips and component mismatches,\" said a source with direct knowledge of the conversations.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3518,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608178049,"gmtCreate":1638672483275,"gmtModify":1638672483451,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608178049","repostId":"1140678193","repostType":4,"isVote":1,"tweetType":1,"viewCount":3385,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608938700,"gmtCreate":1638592190001,"gmtModify":1638592193722,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608938700","repostId":"1174181873","repostType":4,"repost":{"id":"1174181873","kind":"news","pubTimestamp":1638578178,"share":"https://www.laohu8.com/m/news/1174181873?lang=zh_CN&edition=full","pubTime":"2021-12-04 08:36","market":"us","language":"en","title":"US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week<blockquote>美国IPO周：数字银行和云基础设施引领IPO周4</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1174181873","media":"renaissancecap...","summary":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billi","content":"<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p><p><blockquote>IPO市场预计将在未来一周回暖，预计将有四起IPO筹集37亿美元。</blockquote></p><p> Buffett-backed&nbsp;<b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p><p><blockquote>巴菲特支持<b>Nu控股</b>(NU)计划以411亿美元的市值筹集25亿美元。这家巴西纯在线银行成立于2013年，名为Nubank，旨在推出具有移动优先客户体验的免费信用卡产品，但此后已扩展到提供各种其他金融产品。Nu自成立以来发展迅速，目前拥有近5000万客户群，尽管随着客户群的增长，每个客户的收入一直在下降。</blockquote></p><p> Cloud infrastructure platform&nbsp;<b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&amp;M spend.</p><p><blockquote>云基础设施平台<b>哈希公司</b>(HCP)计划以140亿美元的市值筹集11亿美元。这家风险投资支持的公司提供了一套解决方案，可标准化和自动化大规模云基础设施的配置、保护、连接和运行。尽管HashiCorp表现出快速增长和粘性客户群，但由于S&amp;M支出，HashiCorp非常无利可图。</blockquote></p><p> Cannabis finance REIT&nbsp;<b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p><p><blockquote>大麻金融房地产投资信托基金<b>芝加哥大西洋房地产金融</b>(REFI)计划以2.96亿美元的市值筹集1.06亿美元。这个新成立的房地产投资信托基金专注于发起、构建和投资由商业房地产担保的第一抵押贷款和另类结构性融资。其目前的投资组合包括向大麻行业国家许可运营商提供的高级贷款。</blockquote></p><p> Canadian gold exploration company&nbsp;<b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p><p><blockquote>加拿大黄金勘探公司<b>奥斯汀·戈尔德</b>(AUST)计划以6400万美元的市值筹集1500万美元。这家加拿大黄金勘探公司目前拥有位于内华达州的四处地产的权益，目前只有一处地产被认为是重要的。迄今为止，奥斯汀黄金尚未产生任何营业收入。</blockquote></p><p></p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week<blockquote>美国IPO周：数字银行和云基础设施引领IPO周4</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week<blockquote>美国IPO周：数字银行和云基础设施引领IPO周4</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">renaissancecap...</strong><span class=\"h-time small\">2021-12-04 08:36</span>\n</p>\n</h4>\n</header>\n<article>\n<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p><p><blockquote>IPO市场预计将在未来一周回暖，预计将有四起IPO筹集37亿美元。</blockquote></p><p> Buffett-backed&nbsp;<b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p><p><blockquote>巴菲特支持<b>Nu控股</b>(NU)计划以411亿美元的市值筹集25亿美元。这家巴西纯在线银行成立于2013年，名为Nubank，旨在推出具有移动优先客户体验的免费信用卡产品，但此后已扩展到提供各种其他金融产品。Nu自成立以来发展迅速，目前拥有近5000万客户群，尽管随着客户群的增长，每个客户的收入一直在下降。</blockquote></p><p> Cloud infrastructure platform&nbsp;<b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&amp;M spend.</p><p><blockquote>云基础设施平台<b>哈希公司</b>(HCP)计划以140亿美元的市值筹集11亿美元。这家风险投资支持的公司提供了一套解决方案，可标准化和自动化大规模云基础设施的配置、保护、连接和运行。尽管HashiCorp表现出快速增长和粘性客户群，但由于S&amp;M支出，HashiCorp非常无利可图。</blockquote></p><p> Cannabis finance REIT&nbsp;<b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p><p><blockquote>大麻金融房地产投资信托基金<b>芝加哥大西洋房地产金融</b>(REFI)计划以2.96亿美元的市值筹集1.06亿美元。这个新成立的房地产投资信托基金专注于发起、构建和投资由商业房地产担保的第一抵押贷款和另类结构性融资。其目前的投资组合包括向大麻行业国家许可运营商提供的高级贷款。</blockquote></p><p> Canadian gold exploration company&nbsp;<b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p><p><blockquote>加拿大黄金勘探公司<b>奥斯汀·戈尔德</b>(AUST)计划以6400万美元的市值筹集1500万美元。这家加拿大黄金勘探公司目前拥有位于内华达州的四处地产的权益，目前只有一处地产被认为是重要的。迄今为止，奥斯汀黄金尚未产生任何营业收入。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee\">renaissancecap...</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NU":"Nu Holdings Ltd.","HCP":"HashiCorp, Inc.","REFI":"Chicago Atlantic Real Estate Finance, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174181873","content_text":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.\nCloud infrastructure platform HashiCorp(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.\nCannabis finance REIT Chicago Atlantic Real Estate Finance(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.\nCanadian gold exploration company Austin Gold(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.","news_type":1,"symbols_score_info":{"NU":0.9,"REFI":0.9,"HCP":0.9}},"isVote":1,"tweetType":1,"viewCount":2849,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601107013,"gmtCreate":1638495675368,"gmtModify":1638495675542,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601107013","repostId":"1135191762","repostType":4,"isVote":1,"tweetType":1,"viewCount":2358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603614292,"gmtCreate":1638405175121,"gmtModify":1638405175595,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Sad","listText":"Sad","text":"Sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603614292","repostId":"1196358645","repostType":4,"isVote":1,"tweetType":1,"viewCount":677,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609757352,"gmtCreate":1638331038898,"gmtModify":1638331039071,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609757352","repostId":"1101502249","repostType":4,"repost":{"id":"1101502249","kind":"news","pubTimestamp":1638330314,"share":"https://www.laohu8.com/m/news/1101502249?lang=zh_CN&edition=full","pubTime":"2021-12-01 11:45","market":"us","language":"en","title":"Regeneron's COVID-19 antibody drug may be less effective against Omicron<blockquote>再生元新冠抗体药物对奥密克戎病的疗效可能较差</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1101502249","media":"Reuters","summary":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective ag","content":"<p>Nov 30 (Reuters) - <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.</p><p><blockquote>11月30日（路透社）——<a href=\"https://laohu8.com/S/REGN\">再生元制药</a>该公司周二表示，该公司的COVID-19抗体药物对奥密克戎病毒的效果可能较差，在Moderna的最高老板对该公司的疫苗提出类似担忧后，这加剧了人们对现有治疗方法有效性的担忧。</blockquote></p><p> Global markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.</p><p><blockquote>Moderna(MRNA.O)首席执行官的言论重新引发了人们对该变种可能会拖累刚刚起步的全球经济复苏的担忧，全球市场暴跌。</blockquote></p><p> Based on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.</p><p><blockquote>Regeneron(REGN.O)表示，根据对奥密克戎个体突变的研究，“疫苗诱导和单克隆抗体传递免疫的中和活性可能都会降低”，并补充说，该分析包括其COVID-19抗体混合物REGEN-COV。</blockquote></p><p> The company said&nbsp;it was doing further study to quantify the potential impact using the variant's genetic sequence.</p><p><blockquote>该公司表示，正在进行进一步研究，以利用该变种的基因序列量化潜在影响。</blockquote></p><p> One of the antibodies&nbsp;used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.</p><p><blockquote>首席执行官莱恩·施莱弗(Len Schleifer)在接受CNBC采访时表示，治疗中使用的一种抗体可能会受到影响，而另一种则不会受到影响。</blockquote></p><p> \"<a href=\"https://laohu8.com/S/JE\">Just</a> like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"</p><p><blockquote>\"<a href=\"https://laohu8.com/S/JE\">刚刚</a>就像疫苗必须适应一样，我们可能必须不断适应我们的单克隆抗体。”</blockquote></p><p> <a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a> Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.</p><p><blockquote><a href=\"https://laohu8.com/S/LLY\">礼来公司和</a>Co(LLY.N)在一份电子邮件声明中告诉路透社，该公司也在努力了解其疗法对奥密克戎的中和活性。</blockquote></p><p> Regeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.</p><p><blockquote>Regeneron股价在早盘交易中下跌约3%，Lillyshed股价下跌2.5%。</blockquote></p><p> Rival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.</p><p><blockquote>竞争对手Vir Biotechnology Inc(VIR.O)表示，基于奥密克戎序列，其抗体疗法sotrovimab可能会保持针对该变种的效力。</blockquote></p><p> The company is \"working to confirm this in the lab as a matter of urgency\", it added.</p><p><blockquote>它补充说，该公司正在“紧急努力在实验室中确认这一点”。</blockquote></p><p> Gilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron</p><p><blockquote>吉利德公司(GILD.O)表示，相信其静脉注射疗法瑞德西韦(Remdesivir)是目前唯一被批准用于治疗COVID-19的抗病毒药物，将继续有效对抗目前发现的变异体，包括奥密克戎病毒</blockquote></p><p> The U.S. Food &amp; Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.</p><p><blockquote>美国食品和药物管理局周二表示，正在评估授权的COVID-19疫苗针对奥密克戎病毒的有效性，并预计在未来几周内获得更多信息。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron's COVID-19 antibody drug may be less effective against Omicron<blockquote>再生元新冠抗体药物对奥密克戎病的疗效可能较差</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron's COVID-19 antibody drug may be less effective against Omicron<blockquote>再生元新冠抗体药物对奥密克戎病的疗效可能较差</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-12-01 11:45</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Nov 30 (Reuters) - <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.</p><p><blockquote>11月30日（路透社）——<a href=\"https://laohu8.com/S/REGN\">再生元制药</a>该公司周二表示，该公司的COVID-19抗体药物对奥密克戎病毒的效果可能较差，在Moderna的最高老板对该公司的疫苗提出类似担忧后，这加剧了人们对现有治疗方法有效性的担忧。</blockquote></p><p> Global markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.</p><p><blockquote>Moderna(MRNA.O)首席执行官的言论重新引发了人们对该变种可能会拖累刚刚起步的全球经济复苏的担忧，全球市场暴跌。</blockquote></p><p> Based on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.</p><p><blockquote>Regeneron(REGN.O)表示，根据对奥密克戎个体突变的研究，“疫苗诱导和单克隆抗体传递免疫的中和活性可能都会降低”，并补充说，该分析包括其COVID-19抗体混合物REGEN-COV。</blockquote></p><p> The company said&nbsp;it was doing further study to quantify the potential impact using the variant's genetic sequence.</p><p><blockquote>该公司表示，正在进行进一步研究，以利用该变种的基因序列量化潜在影响。</blockquote></p><p> One of the antibodies&nbsp;used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.</p><p><blockquote>首席执行官莱恩·施莱弗(Len Schleifer)在接受CNBC采访时表示，治疗中使用的一种抗体可能会受到影响，而另一种则不会受到影响。</blockquote></p><p> \"<a href=\"https://laohu8.com/S/JE\">Just</a> like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"</p><p><blockquote>\"<a href=\"https://laohu8.com/S/JE\">刚刚</a>就像疫苗必须适应一样，我们可能必须不断适应我们的单克隆抗体。”</blockquote></p><p> <a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a> Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.</p><p><blockquote><a href=\"https://laohu8.com/S/LLY\">礼来公司和</a>Co(LLY.N)在一份电子邮件声明中告诉路透社，该公司也在努力了解其疗法对奥密克戎的中和活性。</blockquote></p><p> Regeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.</p><p><blockquote>Regeneron股价在早盘交易中下跌约3%，Lillyshed股价下跌2.5%。</blockquote></p><p> Rival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.</p><p><blockquote>竞争对手Vir Biotechnology Inc(VIR.O)表示，基于奥密克戎序列，其抗体疗法sotrovimab可能会保持针对该变种的效力。</blockquote></p><p> The company is \"working to confirm this in the lab as a matter of urgency\", it added.</p><p><blockquote>它补充说，该公司正在“紧急努力在实验室中确认这一点”。</blockquote></p><p> Gilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron</p><p><blockquote>吉利德公司(GILD.O)表示，相信其静脉注射疗法瑞德西韦(Remdesivir)是目前唯一被批准用于治疗COVID-19的抗病毒药物，将继续有效对抗目前发现的变异体，包括奥密克戎病毒</blockquote></p><p> The U.S. Food &amp; Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.</p><p><blockquote>美国食品和药物管理局周二表示，正在评估授权的COVID-19疫苗针对奥密克戎病毒的有效性，并预计在未来几周内获得更多信息。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/\">Reuters</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","LLY":"礼来","REGN":"再生元制药公司","GILD":"吉利德科学"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101502249","content_text":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.\nGlobal markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.\nBased on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.\nThe company said it was doing further study to quantify the potential impact using the variant's genetic sequence.\nOne of the antibodies used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.\n\"Just like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"\nEli Lilly and Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.\nRegeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.\nRival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.\nThe company is \"working to confirm this in the lab as a matter of urgency\", it added.\nGilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron\nThe U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.","news_type":1,"symbols_score_info":{"MRNA":0.9,"LLY":0.9,"GILD":0.9,"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1040,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609307685,"gmtCreate":1638236442502,"gmtModify":1638237120769,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/609307685","repostId":"1122315710","repostType":4,"isVote":1,"tweetType":1,"viewCount":790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600669738,"gmtCreate":1638147910041,"gmtModify":1638147910215,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600669738","repostId":"1147238879","repostType":4,"repost":{"id":"1147238879","kind":"news","pubTimestamp":1638145523,"share":"https://www.laohu8.com/m/news/1147238879?lang=zh_CN&edition=full","pubTime":"2021-11-29 08:25","market":"us","language":"en","title":"Amazon Dominates Holiday Price War, Causes Retail Ripple Effect<blockquote>亚马逊主导假日价格战引发零售连锁反应</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147238879","media":"Benzinga","summary":"The holiday shopping season is in full swing, although many customers are finding  higher prices on ","content":"<p><div> The holiday shopping season is in full swing, although many customers are finding  higher prices on products in the market. They're also witnessing an ongoing price warbetween various retail giants. ...</p><p><blockquote><div>假日购物季正在如火如荼地进行，尽管许多顾客发现市场上的产品价格更高。他们也见证了各种零售巨头之间持续的价格战。...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24321958/amazon-dominates-holiday-price-war-causes-retail-ripple-effect\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24321958/amazon-dominates-holiday-price-war-causes-retail-ripple-effect\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon Dominates Holiday Price War, Causes Retail Ripple Effect<blockquote>亚马逊主导假日价格战引发零售连锁反应</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon Dominates Holiday Price War, Causes Retail Ripple Effect<blockquote>亚马逊主导假日价格战引发零售连锁反应</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-29 08:25</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The holiday shopping season is in full swing, although many customers are finding  higher prices on products in the market. They're also witnessing an ongoing price warbetween various retail giants. ...</p><p><blockquote><div>假日购物季正在如火如荼地进行，尽管许多顾客发现市场上的产品价格更高。他们也见证了各种零售巨头之间持续的价格战。...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24321958/amazon-dominates-holiday-price-war-causes-retail-ripple-effect\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24321958/amazon-dominates-holiday-price-war-causes-retail-ripple-effect\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/24321958/amazon-dominates-holiday-price-war-causes-retail-ripple-effect\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.benzinga.com/news/21/11/24321958/amazon-dominates-holiday-price-war-causes-retail-ripple-effect","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147238879","content_text":"The holiday shopping season is in full swing, although many customers are finding  higher prices on products in the market. They're also witnessing an ongoing price warbetween various retail giants.\nAccording to the data analytics company Profitero,Amazon.com, Inc is the first retail firm to increase its prices.\nProfitero tracks almost 20,000 popular items in the online retailsector. It finds that Amazon’s prices on those products increased by 7.5 percent last month compared with October 2020.\nWalmart Inc’s prices grew by 3.1 percent during that period, and Target Corporation raised prices by 3.6 percent.\nHowever, even with the price increases on Amazon, Profitero found that Walmart’s prices on the 20,000 items are 4 percent higher than Amazon’s prices, and Target’s prices are 15 percent higher.\nAccording to Harvard Business School economist Albert Cavallo, Amazon plays a major role in influencing prices across the web.\n“Online competition is a force for price uniformity, and therefore also inflation equalization. And as retailers get better at bringing online pricing, with its frequent swings, to their physical stores, the Amazon Effect becomes an even greater force,” the Washington Post quoted Cavallo saying.\nRetailers are facing a post pandemic supply-chain crunch, affecting sellers worldwide, amplified by the domestic labor shortage and related costs.\nAmazon plans to spend $4 billion to attract seasonal workers in the fourth quarter, with the goal of hiring 15,000 workers during the busy holiday period.","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":981,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600806191,"gmtCreate":1638110998409,"gmtModify":1638110998576,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600806191","repostId":"2186432895","repostType":4,"isVote":1,"tweetType":1,"viewCount":840,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877771238,"gmtCreate":1637993402984,"gmtModify":1637993403168,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877771238","repostId":"2186344334","repostType":4,"isVote":1,"tweetType":1,"viewCount":923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877125035,"gmtCreate":1637900859043,"gmtModify":1637900859162,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877125035","repostId":"2186399793","repostType":4,"isVote":1,"tweetType":1,"viewCount":1003,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874220544,"gmtCreate":1637794666688,"gmtModify":1637794666847,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874220544","repostId":"2186363038","repostType":4,"isVote":1,"tweetType":1,"viewCount":801,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874928834,"gmtCreate":1637721910743,"gmtModify":1637721910859,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874928834","repostId":"2185336565","repostType":4,"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872831098,"gmtCreate":1637469645872,"gmtModify":1637469645990,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872831098","repostId":"1156888846","repostType":4,"repost":{"id":"1156888846","kind":"news","pubTimestamp":1637465976,"share":"https://www.laohu8.com/m/news/1156888846?lang=zh_CN&edition=full","pubTime":"2021-11-21 11:39","market":"us","language":"en","title":"Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156888846","media":"Benzinga","summary":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shel","content":"<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Ford Is Terminating Its Joint EV Development Plan With Rivian?<blockquote>为什么福特终止与Rivian的联合电动汽车开发计划？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Benzinga</strong><span class=\"h-time small\">2021-11-21 11:39</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether. What Happened:As Ford steps on the gas on...</p><p><blockquote><div>福特汽车公司是电动汽车初创公司Rivian汽车公司的早期支持者之一，该公司正在完全搁置与后者开发电动汽车的计划。发生了什么：当福特踩下油门时...</div></blockquote></p><p>  <a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian\">Benzinga</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","F":"福特汽车"},"source_url":"https://www.benzinga.com/news/21/11/24209309/why-ford-is-terminating-its-joint-ev-development-plan-with-rivian","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156888846","content_text":"Ford Motor Company, which is one of the early backers of EV startup Rivian Automotive, Inc., is shelving its plan to develop an EV with the latter altogether.\nWhat Happened:As Ford steps on the gas on its EV transition, the Detroit-based automaker has decided to abandon it plans to jointly develop an EV with Rivian, CEO Jim Farley said in an interview with Automotive News.\nFarley said Ford expects to produce 600,000 vehicles per year by the end of 2023.\nWhen Ford initially invested $500 million in Rivian in 2019, it envisaged developing a Ford branded EV that will come with Rivian's skateboard powertrain. In early 2020, the companies said they are shelving the plans for a Lincoln-branded EV but would go ahead with an alternative vehicle based on Rivian technology.\nThe Ford CEO suggested in the interview that the company is now increasingly confident in competing in the EV space by itself. Another handicap that forced the going-solo decision was the complexities involved in integrating the hardware and software together.\nWhy It's Important:Rivian shares debuted on Wall Street on Nov. 10 following aninitial public offeringat a bumper valuation of over $100 billion. The company's strong debut and the subsequent run up in shares have raised eyebrows over its valuation which has taken it past the market capitalization of legacy U.S. automakers, including Ford.\nRivian's product pipeline consists of RIT, an EV pickup truck, which it began delivering to customers in September. As of Oct. 30, the company produced 180 R1Ts and delivered 156 R1Ts, with the bulk of them going to the company's employees.\nThe company noted that at the end of October, it had preorders of about 55,400 R1Ts and R1Ss. It expects to fill the preorder backlog by the end of 2023.\nFord, for its part, has doubled on itsEV strategyand invested big dollars into its transition toward EVs.\n\"We respect Rivian and have had extensive exploratory discussions with them, however, both sides have agreed not to pursue any kind of joint vehicle development or platform sharing,\" Ford said in an emailed statement to media.\nRivian, meanwhile, confirmed that it is a mutual decision to focus on each of their own projects and deliveries, given Ford has scaled its own EV strategy and demand for Rivian vehicles has grown.\n\"Our relationship with Ford is an important part of our journey, and Ford remains an investor and ally on our shared path to an electrified future\" a Rivian spokesperson said.\nRivian closed Friday's session up 4.23% at $128.60, while Ford closed down 0.87% at $19.39.","news_type":1,"symbols_score_info":{"RIVN":0.9,"F":0.9}},"isVote":1,"tweetType":1,"viewCount":963,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":156017856,"gmtCreate":1625186020175,"gmtModify":1633942804072,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/156017856","repostId":"2148827233","repostType":4,"isVote":1,"tweetType":1,"viewCount":669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":877125035,"gmtCreate":1637900859043,"gmtModify":1637900859162,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877125035","repostId":"2186399793","repostType":4,"isVote":1,"tweetType":1,"viewCount":1003,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":172258392,"gmtCreate":1626963611116,"gmtModify":1633769316835,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Ggwp","listText":"Ggwp","text":"Ggwp","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/172258392","repostId":"1139354130","repostType":4,"repost":{"id":"1139354130","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626962203,"share":"https://www.laohu8.com/m/news/1139354130?lang=zh_CN&edition=full","pubTime":"2021-07-22 21:56","market":"us","language":"en","title":"Bilibili fell over 5% in morning trading<blockquote>哔哩哔哩早盘跌超5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1139354130","media":"Tiger Newspress","summary":"(July 22) Bilibili Inc. fell over 5% in morning trading.","content":"<p>(July 22)&nbsp;<a href=\"https://laohu8.com/S/BILI\">Bilibili Inc.</a> fell over 5% in morning trading.</p><p><blockquote>（7月22日）<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>早盘跌超5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f2f2967080636503f5d7b0d41cc6698f\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bilibili fell over 5% in morning trading<blockquote>哔哩哔哩早盘跌超5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBilibili fell over 5% in morning trading<blockquote>哔哩哔哩早盘跌超5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-22 21:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>(July 22)&nbsp;<a href=\"https://laohu8.com/S/BILI\">Bilibili Inc.</a> fell over 5% in morning trading.</p><p><blockquote>（7月22日）<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>早盘跌超5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f2f2967080636503f5d7b0d41cc6698f\" tg-width=\"704\" tg-height=\"486\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09626":"哔哩哔哩-W","BILI":"哔哩哔哩"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139354130","content_text":"(July 22) Bilibili Inc. fell over 5% in morning trading.","news_type":1,"symbols_score_info":{"09626":0.9,"BILI":0.9}},"isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153180050,"gmtCreate":1625013418270,"gmtModify":1633945898662,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"More yays","listText":"More yays","text":"More yays","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/153180050","repostId":"1122418477","repostType":4,"isVote":1,"tweetType":1,"viewCount":612,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":877771238,"gmtCreate":1637993402984,"gmtModify":1637993403168,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/877771238","repostId":"2186344334","repostType":4,"isVote":1,"tweetType":1,"viewCount":923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874928834,"gmtCreate":1637721910743,"gmtModify":1637721910859,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874928834","repostId":"2185336565","repostType":4,"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":832865745,"gmtCreate":1629607734187,"gmtModify":1631893007332,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/832865745","repostId":"1158638011","repostType":4,"repost":{"id":"1158638011","kind":"news","pubTimestamp":1629602404,"share":"https://www.laohu8.com/m/news/1158638011?lang=zh_CN&edition=full","pubTime":"2021-08-22 11:20","market":"us","language":"en","title":"American consumers’ gray mood could put the S&P 500 in the green over the next 6 months<blockquote>美国消费者的灰色情绪可能会让标普500在未来6个月内变得绿色</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1158638011","media":"MarketWatch","summary":"Consumers’ sentiment is a contrarian indicator, so their current pessimism is bullish for stocks.\n\nL","content":"<p>  <b>Consumers’ sentiment is a contrarian indicator, so their current pessimism is bullish for stocks.</b>  Last week’s unexpected plunge in the University of Michigan Consumer Sentiment Index is actually good news for U.S. stock investors. That’s because the American consumer is a contrarian stock-market indicator. More often than not over the past four decades, large declines in consumer confidence have been followed by above-average stock market returns.</p><p><blockquote><b>消费者情绪是一个逆向指标，因此他们目前的悲观情绪对股市有利。</b>上周密歇根大学消费者信心指数意外暴跌，对美股投资者来说其实是个好消息。这是因为美国消费者是股市的逆向指标。在过去的四十年里，消费者信心大幅下降之后往往会出现高于平均水平的股市回报。</blockquote></p><p> This should come as a big relief for Wall Street bulls, who have otherwise been fretting about the University of Michigan index’s latest reading. From a July level of 81.2,the index fell last week to 70.2. That’s the lowest since December 2011 — lower even than the lowest reading registered in the darkest early weeks of the COVID-19 pandemic.</p><p><blockquote>这应该会让华尔街多头松一口气，否则他们一直对密歇根大学指数的最新读数感到担忧。该指数从7月份的81.2降至上周的70.2。这是自2011年12月以来的最低水平，甚至低于COVID-19大流行最黑暗的最初几周记录的最低读数。</blockquote></p><p> To appreciate how much this latest reading was unexpected, consider that the economists surveyed in advance by MarketWatch were predicting, on average, that the index would come in at 81.3 — a slight right rise from the July number.</p><p><blockquote>要了解这一最新读数有多出乎意料，请考虑一下MarketWatch提前调查的经济学家平均预测该指数将为81.3，比7月份的数字略有上升。</blockquote></p><p> To analyze the significance of drops as big as this latest one, I calculated the correlations between monthly changes in the University of Michigan index since 1978 and the S&amp;P 500’sSPX,+0.81%subsequent performance on both an inflation- and dividend-adjusted basis. I found that whenever this sentiment index dropped by at least 10 percentage points, the S&amp;P 500 over the subsequent three months gained an average of 3.6%.</p><p><blockquote>为了分析像最近一次这样大幅下跌的重要性，我计算了自1978年以来密歇根大学指数的月度变化与标普500 SPX之间的相关性，在通胀和股息调整的基础上，随后的表现为+0.81%。我发现，每当这一情绪指数下降至少10个百分点时，随后三个月的标普500平均上涨3.6%。</blockquote></p><p> That’s double the 1.7% average three-month gain following months in which the consumer sentiment index gained at least 10 percentage points. Moreover, as evident in the chart below, this contrast at the six-month horizon is even greater: 7.5% versus 2.6%.</p><p><blockquote>这是消费者信心指数上涨至少10个百分点后三个月平均涨幅1.7%的两倍。此外，如下图所示，六个月内的反差甚至更大：7.5%对2.6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/db16295aee3c6f4bbf094317ade3d200\" tg-width=\"700\" tg-height=\"486\" width=\"100%\" height=\"auto\">To be sure, there aren’t that many months since 1978 in which the consumer sentiment index rose or fell by this much. The inverse relationship between the sentiment index’s monthly changes and the U.S. stock market’s subsequent performance is only marginally statistically significant. So you should not use the occasion of the sentiment index’s big drop to throw caution to the wind.</p><p><blockquote>可以肯定的是，自1978年以来，消费者信心指数上涨或下跌幅度如此之大的月份并不多。情绪指数的月度变化与美股市场后续表现之间的反比关系仅具有边际统计意义。所以你不应该利用情绪指数大跌的机会把谨慎抛到九霄云外。</blockquote></p><p> Nevertheless, if you want to believe that this historical relationship is statistically insignificant, you still can’t conclude that this most recent drop is a bad sign. You’d instead have to conclude that the University of Michigan index tells you nothing about the stock market’s prospects in coming months.</p><p><blockquote>尽管如此，如果你想相信这种历史关系在统计上是微不足道的，你仍然不能断定最近的这种下降是一个不好的迹象。相反，你不得不得出结论，密歇根大学指数没有告诉你任何关于未来几个月股市前景的信息。</blockquote></p><p> So there you have it. Either this latest drop means nothing, or it is bullish. If you want to believe that this latest drop is bad news, you will have to base your argument on something other than U.S. stock market history since 1978.</p><p><blockquote>所以你有它。要么最近的下跌毫无意义，要么就是看涨。如果你想相信最近的下跌是坏消息，你就必须把你的论点建立在1978年以来美国股市历史以外的东西上。</blockquote></p><p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>American consumers’ gray mood could put the S&P 500 in the green over the next 6 months<blockquote>美国消费者的灰色情绪可能会让标普500在未来6个月内变得绿色</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmerican consumers’ gray mood could put the S&P 500 in the green over the next 6 months<blockquote>美国消费者的灰色情绪可能会让标普500在未来6个月内变得绿色</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">MarketWatch</strong><span class=\"h-time small\">2021-08-22 11:20</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  <b>Consumers’ sentiment is a contrarian indicator, so their current pessimism is bullish for stocks.</b>  Last week’s unexpected plunge in the University of Michigan Consumer Sentiment Index is actually good news for U.S. stock investors. That’s because the American consumer is a contrarian stock-market indicator. More often than not over the past four decades, large declines in consumer confidence have been followed by above-average stock market returns.</p><p><blockquote><b>消费者情绪是一个逆向指标，因此他们目前的悲观情绪对股市有利。</b>上周密歇根大学消费者信心指数意外暴跌，对美股投资者来说其实是个好消息。这是因为美国消费者是股市的逆向指标。在过去的四十年里，消费者信心大幅下降之后往往会出现高于平均水平的股市回报。</blockquote></p><p> This should come as a big relief for Wall Street bulls, who have otherwise been fretting about the University of Michigan index’s latest reading. From a July level of 81.2,the index fell last week to 70.2. That’s the lowest since December 2011 — lower even than the lowest reading registered in the darkest early weeks of the COVID-19 pandemic.</p><p><blockquote>这应该会让华尔街多头松一口气，否则他们一直对密歇根大学指数的最新读数感到担忧。该指数从7月份的81.2降至上周的70.2。这是自2011年12月以来的最低水平，甚至低于COVID-19大流行最黑暗的最初几周记录的最低读数。</blockquote></p><p> To appreciate how much this latest reading was unexpected, consider that the economists surveyed in advance by MarketWatch were predicting, on average, that the index would come in at 81.3 — a slight right rise from the July number.</p><p><blockquote>要了解这一最新读数有多出乎意料，请考虑一下MarketWatch提前调查的经济学家平均预测该指数将为81.3，比7月份的数字略有上升。</blockquote></p><p> To analyze the significance of drops as big as this latest one, I calculated the correlations between monthly changes in the University of Michigan index since 1978 and the S&amp;P 500’sSPX,+0.81%subsequent performance on both an inflation- and dividend-adjusted basis. I found that whenever this sentiment index dropped by at least 10 percentage points, the S&amp;P 500 over the subsequent three months gained an average of 3.6%.</p><p><blockquote>为了分析像最近一次这样大幅下跌的重要性，我计算了自1978年以来密歇根大学指数的月度变化与标普500 SPX之间的相关性，在通胀和股息调整的基础上，随后的表现为+0.81%。我发现，每当这一情绪指数下降至少10个百分点时，随后三个月的标普500平均上涨3.6%。</blockquote></p><p> That’s double the 1.7% average three-month gain following months in which the consumer sentiment index gained at least 10 percentage points. Moreover, as evident in the chart below, this contrast at the six-month horizon is even greater: 7.5% versus 2.6%.</p><p><blockquote>这是消费者信心指数上涨至少10个百分点后三个月平均涨幅1.7%的两倍。此外，如下图所示，六个月内的反差甚至更大：7.5%对2.6%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/db16295aee3c6f4bbf094317ade3d200\" tg-width=\"700\" tg-height=\"486\" width=\"100%\" height=\"auto\">To be sure, there aren’t that many months since 1978 in which the consumer sentiment index rose or fell by this much. The inverse relationship between the sentiment index’s monthly changes and the U.S. stock market’s subsequent performance is only marginally statistically significant. So you should not use the occasion of the sentiment index’s big drop to throw caution to the wind.</p><p><blockquote>可以肯定的是，自1978年以来，消费者信心指数上涨或下跌幅度如此之大的月份并不多。情绪指数的月度变化与美股市场后续表现之间的反比关系仅具有边际统计意义。所以你不应该利用情绪指数大跌的机会把谨慎抛到九霄云外。</blockquote></p><p> Nevertheless, if you want to believe that this historical relationship is statistically insignificant, you still can’t conclude that this most recent drop is a bad sign. You’d instead have to conclude that the University of Michigan index tells you nothing about the stock market’s prospects in coming months.</p><p><blockquote>尽管如此，如果你想相信这种历史关系在统计上是微不足道的，你仍然不能断定最近的这种下降是一个不好的迹象。相反，你不得不得出结论，密歇根大学指数没有告诉你任何关于未来几个月股市前景的信息。</blockquote></p><p> So there you have it. Either this latest drop means nothing, or it is bullish. If you want to believe that this latest drop is bad news, you will have to base your argument on something other than U.S. stock market history since 1978.</p><p><blockquote>所以你有它。要么最近的下跌毫无意义，要么就是看涨。如果你想相信最近的下跌是坏消息，你就必须把你的论点建立在1978年以来美国股市历史以外的东西上。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.marketwatch.com/story/american-consumers-gray-mood-could-put-the-s-p-500-in-the-green-over-the-next-6-months-11629181914?mod=home-page\">MarketWatch</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.marketwatch.com/story/american-consumers-gray-mood-could-put-the-s-p-500-in-the-green-over-the-next-6-months-11629181914?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158638011","content_text":"Consumers’ sentiment is a contrarian indicator, so their current pessimism is bullish for stocks.\n\nLast week’s unexpected plunge in the University of Michigan Consumer Sentiment Index is actually good news for U.S. stock investors. That’s because the American consumer is a contrarian stock-market indicator. More often than not over the past four decades, large declines in consumer confidence have been followed by above-average stock market returns.\nThis should come as a big relief for Wall Street bulls, who have otherwise been fretting about the University of Michigan index’s latest reading. From a July level of 81.2,the index fell last week to 70.2. That’s the lowest since December 2011 — lower even than the lowest reading registered in the darkest early weeks of the COVID-19 pandemic.\nTo appreciate how much this latest reading was unexpected, consider that the economists surveyed in advance by MarketWatch were predicting, on average, that the index would come in at 81.3 — a slight right rise from the July number.\nTo analyze the significance of drops as big as this latest one, I calculated the correlations between monthly changes in the University of Michigan index since 1978 and the S&P 500’sSPX,+0.81%subsequent performance on both an inflation- and dividend-adjusted basis. I found that whenever this sentiment index dropped by at least 10 percentage points, the S&P 500 over the subsequent three months gained an average of 3.6%.\nThat’s double the 1.7% average three-month gain following months in which the consumer sentiment index gained at least 10 percentage points. Moreover, as evident in the chart below, this contrast at the six-month horizon is even greater: 7.5% versus 2.6%.\nTo be sure, there aren’t that many months since 1978 in which the consumer sentiment index rose or fell by this much. The inverse relationship between the sentiment index’s monthly changes and the U.S. stock market’s subsequent performance is only marginally statistically significant. So you should not use the occasion of the sentiment index’s big drop to throw caution to the wind.\nNevertheless, if you want to believe that this historical relationship is statistically insignificant, you still can’t conclude that this most recent drop is a bad sign. You’d instead have to conclude that the University of Michigan index tells you nothing about the stock market’s prospects in coming months.\nSo there you have it. Either this latest drop means nothing, or it is bullish. If you want to believe that this latest drop is bad news, you will have to base your argument on something other than U.S. stock market history since 1978.","news_type":1,"symbols_score_info":{".DJI":0.9,"SPY":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":467,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891221861,"gmtCreate":1628393125653,"gmtModify":1633747412392,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/891221861","repostId":"1190347839","repostType":4,"isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123355391,"gmtCreate":1624410196813,"gmtModify":1634006562591,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Good news","listText":"Good news","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/123355391","repostId":"2145664330","repostType":4,"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873009243,"gmtCreate":1636783734272,"gmtModify":1636783734383,"author":{"id":"3581764784067746","authorId":"3581764784067746","name":"kencarrot","avatar":"https://static.tigerbbs.com/99bb3314847ae532130ee6780cc9cd98","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581764784067746","authorIdStr":"3581764784067746"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873009243","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s&nbsp;chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上，辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时，听起来很头晕。就在几天前，他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说：“你能够打破这种类型的世界纪录，同时偶然获得大满贯，这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利：在短短10个月内开发出了一种效果惊人的Covid-19疫苗，一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前，辉瑞（股票代码：PFE）首席执行官阿尔伯特·布尔拉（Albert Bourla）要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品，留下了一家纯粹的生物制药公司，该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中，<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而，随着对全球疫苗分配不平等的批评越来越多，继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中，低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家，该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like&nbsp;Johnson &amp; Johnson&nbsp;(JNJ) and&nbsp;Eli Lilly&nbsp;(LLY).</p><p><blockquote>数据公布当天，辉瑞股价飙升10.9%，创下至少20年来的最佳单日表现。尽管如此，由于该股目前易手价格约为50美元，投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍，低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的，但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上，但对于长期投资者来说，这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech&nbsp;BioNTech&nbsp;(BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室，但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期，辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对Covid-19药丸的探索。疫苗工作规模巨大；多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队，拥有相当适中的资源，”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目，其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&amp;D is better than people had thought.”</p><p><blockquote>“（辉瑞的）制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而，辉瑞文库中的蛋白酶抑制剂已经静脉内施用，并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药，这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应，”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物，这个过程通常可能需要数年时间，但他们在几个月内就完成了。“在这里，四年变成了四个月，”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from&nbsp;Merck&nbsp;(MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验，包括一项针对高风险患者，一项针对非高风险患者，以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中，该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&amp;D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示：“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级，目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示，在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前，她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级，”她说。“在这些事情发生之前，我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of&nbsp;Moderna&nbsp;(MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时，Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望，呼吁该公司提高产量，以便能够以非营利价格向低收入国家提供更多剂量，一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续，辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候，辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平，告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗，捐赠给贫穷国家，并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面，辉瑞仅表示将为较贫穷国家提供分级定价，与其疫苗采取的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议，允许其药丸在全球范围内获得许可，无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示，辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择，”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底，活动人士在布尔拉家外抗议，呼吁辉瑞分享其疫苗制造技术，并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评，使辉瑞公司相对受到华盛顿的青睐，并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}